[HTML][HTML] Camu-camu reduces obesity and improves diabetic profiles of obese and diabetic mice: A dose-ranging study

A Abot, A Brochot, N Pomié, E Wemelle, C Druart… - Metabolites, 2022 - mdpi.com
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study.

A Abot, A Brochot, N Pomié, E Wemelle… - Metabolites (2218 …, 2022 - search.ebscohost.com
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

[PDF][PDF] Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study. Metabolites 2022, 12, 301

A Abot, A Brochot, N Pomié, E Wemelle, C Druart… - 2022 - mdpi.com
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study

A Abot, A Brochot, N Pomié, E Wemelle, C Druart… - Metabolites, 2022 - research.wur.nl
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study

A Anne, B Amandine, P Nicolas, W Eve, D Céline… - Metabolites, 2022 - agris.fao.org
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study

A Abot, A Brochot, N Pomié, E Wemelle… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

[PDF][PDF] Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study. Metabolites 2022, 12, 301

A Abot, A Brochot, N Pomié, E Wemelle, C Druart… - 2022 - academia.edu
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

[PDF][PDF] Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study. Metabolites 2022, 12, 301

A Abot, A Brochot, N Pomié, E Wemelle, C Druart… - 2022 - researchgate.net
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

[PDF][PDF] Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study. Metabolites 2022, 12, 301

A Abot, A Brochot, N Pomié, E Wemelle, C Druart… - 2022 - dial.uclouvain.be
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …

[PDF][PDF] Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study. Metabolites 2022, 12, 301

A Abot, A Brochot, N Pomié, E Wemelle, C Druart… - 2022 - researchportal.helsinki.fi
Overweight, obesity, and their comorbidities are currently considered a major public health
concern. Today considerable efforts are still needed to develop efficient strategies able to …